The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis

Update Il y a 4 ans
Reference: NCT00405665

Woman and Man

  • | Country :
  • Canada
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this trial is to determine the safety and effect on pulmonary function of 14 days of inhaled L-arginine versus placebo administered over a period of 14 days in a cohort of CF patients.


Inclusion criteria

  • Cystic fibrosis

Links